<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Andreassen Wrenn | Activity</title>
	<link>https://www.catswannabecats.com/members/africacolt73/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/africacolt73/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Andreassen Wrenn.</description>
	<lastBuildDate>Mon, 29 Jun 2026 10:35:48 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">fd857bb279ca6b7da681331640e510ca</guid>
				<title>Andreassen Wrenn posted an update: Multi-target, especially dual-target, drug design has become [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23911/</link>
				<pubDate>Sun, 08 Jun 2025 10:53:12 -0400</pubDate>

									<content:encoded><![CDATA[<p>Multi-target, especially dual-target, drug design has become a popular research field for cancer treatment. Development of small molecule dual-target inhibitors through hybridization strategy can provide highly potent and selective anticancer agents. In this study, three series of quinazoline derivatives bearing a benzene-sulfonamide moiety were&hellip;<span class="activity-read-more" id="activity-read-more-23911"><a href="https://www.catswannabecats.com/activity/p/23911/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">638377b8dad653573b8c98828c3f1ee1</guid>
				<title>Andreassen Wrenn posted an update: SPSS 16.0 was used for analyzing data. The difference [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/14967/</link>
				<pubDate>Mon, 02 Jun 2025 11:32:23 -0400</pubDate>

									<content:encoded><![CDATA[<p>SPSS 16.0 was used for analyzing data. The difference between the two groups was analyzed by performing Student&#8217;s t-test, and ANOVA was used to analyze the difference when more than two groups. P values less then 0.05 were considered to be significantly different.Our findings demonstrated that the knockdown of lncRNA-AIRN influencedmitophagy in&hellip;<span class="activity-read-more" id="activity-read-more-14967"><a href="https://www.catswannabecats.com/activity/p/14967/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a5cbb6ae7d2babd71f4e88e5275f9d67</guid>
				<title>Andreassen Wrenn posted an update: The Trail Making Test (TMT) is a popular neuropsychological [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/3519/</link>
				<pubDate>Sat, 31 May 2025 10:48:06 -0400</pubDate>

									<content:encoded><![CDATA[<p>The Trail Making Test (TMT) is a popular neuropsychological test derived from the Army Individual Test Battery, which was used by the U.S. Army. Its content was obviously designed within the English cultural context. Consequently, there is ongoing debate regarding TMT&#8217;s applicability on non-English speaking population. The objective of this study&hellip;<span class="activity-read-more" id="activity-read-more-3519"><a href="https://www.catswannabecats.com/activity/p/3519/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f8cc6e7d7d79e4ff94048aeca4db24a6</guid>
				<title>Andreassen Wrenn became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/3433/</link>
				<pubDate>Sat, 31 May 2025 10:41:47 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>